WorldQuant Millennium Advisors
VRTX icon

WorldQuant Millennium Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

WorldQuant Millennium Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-108,002
Closed -$49M – 699
2025
Q4 		$49M Buy
+108,002
New +$46.6M 0.19% 133
2024
Q2 		– Sell
-117,983
Closed -$49.3M – 475
2024
Q1 		$49.3M Sell
117,983
-88,622
-43% -$37.5M 0.61% 39
2023
Q4 		$84.1M Buy
206,605
+68,295
+49% +$25.2M 1.18% 13
2023
Q3 		$48.1M Sell
138,310
-2,355
-2% -$824K 0.74% 28
2023
Q2 		$49.5M Buy
140,665
+139,912
+18,581% +$47.1M 0.84% 16
2023
Q1 		$237K Sell
753
-87,529
-99% -$26.3M ﹤0.01% 345
2022
Q4 		$25.5M Buy
88,282
+56,520
+178% +$17.2M 0.58% 50
2022
Q3 		$9.2M Buy
31,762
+23,055
+265% +$6.63M 0.22% 136
2022
Q2 		$2.45M Buy
+8,707
New +$2.33M 0.07% 239
2021
Q4 		– Sell
-122,737
Closed -$22.3M – 387
2021
Q3 		$22.3M Sell
122,737
-13,726
-10% -$2.68M 0.49% 61
2021
Q2 		$27.5M Buy
136,463
+31,363
+30% +$6.56M 0.61% 45
2021
Q1 		$22.6M Buy
105,100
+9,778
+10% +$2.15M 0.48% 60
2020
Q4 		$22.5M Hold
95,322
– – 0.49% 60
2020
Q3 		$25.9M Buy
95,322
+1,023
+1% +$282K 0.61% 35
2020
Q2 		$27.4M Buy
94,299
+58,172
+161% +$15.8M 0.63% 31
2020
Q1 		$8.6M Sell
36,127
-6,070
-14% -$1.39M 0.21% 143
2019
Q4 		$9.24M Sell
42,197
-137,889
-77% -$27.9M 0.18% 166
2019
Q3 		$30.5M Sell
180,086
-278,140
-61% -$49.2M 0.59% 57
2019
Q2 		$84M Buy
458,226
+63,941
+16% +$11.2M 1.6% 5
2019
Q1 		$72.5M Buy
394,285
+40,802
+12% +$7.54M 1.72% 4
2018
Q4 		$58.6M Buy
353,483
+86,440
+32% +$15M 1.73% 2
2018
Q3 		$51.5M Buy
267,043
+96,331
+56% +$17.2M 1.72% 4
2018
Q2 		$29M Buy
+170,712
New +$26.5M 1.11% 17

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WorldQuant Millennium Advisors's VRTX Position: Q1 2026 in Review

WorldQuant Millennium Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 108,002 shares — an estimated $49M sold.

WorldQuant Millennium Advisors first reported a position in VRTX in Q2 2018 and held it in 23 quarters. The position peaked at $84.1M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • WorldQuant Millennium Advisors reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 108,002 Vertex Pharmaceuticals shares in Q1 2026, an estimated $49M.
  • WorldQuant Millennium Advisors first reported a position in Vertex Pharmaceuticals in Q2 2018 and held it in 23 quarters.
  • WorldQuant Millennium Advisors's Vertex Pharmaceuticals position peaked at $84.1M in Q4 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.